News

Lilly, which has its headquarters in Indianapolis, first announced that it would be seeking approval from Limerick City and ...
Eli Lilly’s expanding US production and advancing pipeline offset near-term headwinds and support bullish conviction. Read ...
Eli Lilly Chief Executive David Ricks said manufacturing of certain drugs could come back to the U.S. if there is an economic incentive, such as lower tax rates for domestic production. "We favor ...
Microsoft and Meta's strong earnings reports eased investor fears of an economic slowdown amid President Trump's tariffs.
US stocks rose on Thursday (May 1) as strong earnings from major tech companies helped calm investor concerns about the ...
Wall Street pushed higher in midday trading, with the S&P 500 on track for its eighth consecutive gain — its longest winning ...
With more production shifting domestically, PCL Construction is helping to meet U.S. biomanufacturing needs with its ...
Eli Lilly CEO Dave Ricks took a stand against Trump's tariffs in a Q1 earnings call. The medicine company has strong operations for obesity and weight loss drugs in Ireland.
As multiple large drugmakers look to navigate trade turbulence by pumping billions of dollars into their U.S. | Eli Lilly CEO Dave Ricks is joining a growing number of pharma chiefs calling for tax ...
Eli Lilly (LLY) is among the list of large-cap pharmaceutical companies that are awaiting the Trump administration's word on ...
The head of drugmaker Eli Lilly, which sells the popular weight-loss drug Zepbound, urged the Trump administration to ease up on its [tariff rollout]( ...